Vident Advisory LLC Makes New Investment in Astera Labs, Inc. $ALAB

Key Points

• Vident Advisory LLC has acquired 3,464 shares of Astera Labs, Inc. for approximately $207,000, marking a significant investment in the company during the first quarter.
• Astera Labs has recently received multiple price target upgrades from analysts, with Evercore ISI raising its target from $104 to $215 and Deutsche Bank lifting it from $160 to $200.
• The company reported 149.5% year-over-year revenue growth for the last quarter, with an earnings per share (EPS) of $0.44, surpassing analysts' expectations of $0.33.

Vident Advisory LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,464 shares of the company's stock, valued at approximately $207,000.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. grew its position in shares of Astera Labs by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after acquiring an additional 85,846 shares during the period. Bank of Nova Scotia increased its holdings in shares of Astera Labs by 3,742.2% in the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock worth $57,546,000 after buying an additional 939,300 shares during the period. Polar Capital Holdings Plc bought a new stake in Astera Labs in the 4th quarter worth $126,812,000. The Manufacturers Life Insurance Company increased its stake in shares of Astera Labs by 116.7% during the first quarter. The Manufacturers Life Insurance Company now owns 662,223 shares of the company's stock valued at $39,515,000 after buying an additional 356,664 shares during the period. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in shares of Astera Labs by 25.2% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 636,536 shares of the company's stock valued at $37,982,000 after purchasing an additional 128,163 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ALAB shares. Evercore ISI lifted their price target on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 6th. Zacks Research raised Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. Barclays reaffirmed an "overweight" rating and issued a $155.00 target price (up previously from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a report on Tuesday, September 2nd. Finally, William Blair started coverage on shares of Astera Labs in a research report on Thursday, May 22nd. They set an "outperform" rating on the stock. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs has a consensus rating of "Moderate Buy" and a consensus target price of $142.00.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $230.37 on Thursday. Astera Labs, Inc. has a 1 year low of $38.14 and a 1 year high of $230.88. The firm has a market capitalization of $38.29 billion, a P/E ratio of 411.38, a P/E/G ratio of 5.44 and a beta of 1.48. The business's 50-day moving average is $149.50 and its 200 day moving average is $101.61.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's revenue for the quarter was up 149.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.13 earnings per share. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Activity at Astera Labs

In related news, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $171.38, for a total value of $17,138,000.00. Following the sale, the chief financial officer directly owned 518,996 shares in the company, valued at approximately $88,945,534.48. The trade was a 16.16% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total value of $47,605,600.00. Following the completion of the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,832,489 shares of company stock worth $264,172,396 in the last quarter. Company insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.